Scientists Launch the First Drug Trial Against Congo’s Bundibugyo Ebola Outbreak

Trump to Request Over $1.4 Billion in Ebola Funding from Congress

Meanwhile, two trials for the treatment of Bundibugyo Ebola will begin soon and France reports its first case. The post Trump to Request Over 1.4 Billion in Ebola Funding from Congress first appeared on Le·gal In·sur·rec·tion.

Africa news roundup: 19-25 June

This week: Ebola in France, a strengthened alliance and tackling South Africa's new No1 killer The post Africa news roundup: 19-25 June appeared first on Research Professional News.

WHO Announces Ebola Treatments Trial in DR Congo

A trial of potential treatments for the Bundibugyo virus species behind the current deadly Ebola outbreak in the Democratic Republic of Congo has begun, the World Health Organisation, WHO, has announced The first patient has been enrolled in DR Congo, WHO chief, Tedros Adhanom Ghebreyesus said on Thursday. More than 1,400 cases and 438 deaths [] The post WHO Announces Ebola Treatments Trial in DR Congo appeared first on Voice of Nigeria.

Trial of potential Ebola treatments begins in DR Congo

GENEVA, Switzerland (AFP) — The trial of two potential treatments for the Bundibugyo species of Ebola behind the deadly outbreak in the DR Congo began in the country on Thursday, the World Health Organization said.There are no approved vaccines or treatments for the rare strain which has been spreading in the northeastern provinces of the Democratic Republic of Congo.There have been 1,406 confirmed cases and 438 confirmed deaths in the DRC, while 208 people have recovered from the virus, according to figures from the WHO.Today, the clinical trial of two therapeutics began, with the enrolment of the first patient, with the trial evaluating the monoclonal antibody MBP134 and the antiviral drug remdesivir, alone and in combination, WHO chief Tedros Adhanom Ghebreyesus told reporters.He said the study was being conducted by the DRC's National Institute for Biomedical Research, backed up by partners including the WHO.Patients who enroll in the trial will receive comprehensive supportive care and close follow-up, Tedros insisted.We are also working to ensure they have access to the two drugs should they prove safe and efficacious in the trial.

New Ebola treatment trial begins in Congo

Residents at the center of Congo’s Ebola crisis are looking to experimental therapies for hope, as researchers in early July launched a long-awaited study examining two potential treatments for the still-expanding outbreak. At the Ebola treatment unit within Bunia’s Evangelical Medical Center in Ituri province, the start of the study unfolded with a sense of [] The post New Ebola treatment trial begins in Congo appeared first on Egyptian Gazette.